Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Ocio, E.M. (Enrique M.) | - |
dc.creator | Bringhen, S. (Sara) | - |
dc.creator | Martínez-López, J. (Joaquín) | - |
dc.creator | San-Miguel, J.F. (Jesús F.) | - |
dc.creator | Oliva, S. (Stefania) | - |
dc.creator | Rodriguez-Otero, P. (Paula) | - |
dc.creator | Le-Roux, N. (Nadia) | - |
dc.creator | Dong, Y. (Yvonne) | - |
dc.creator | Doroumian, S. (Severine) | - |
dc.creator | Mace, S. (Sandrine) | - |
dc.creator | Mateos, M.V. (María Victoria) | - |
dc.date.accessioned | 2023-04-18T09:38:48Z | - |
dc.date.available | 2023-04-18T09:38:48Z | - |
dc.date.issued | 2023 | - |
dc.identifier.issn | 2572-9241 | - |
dc.identifier.uri | https://hdl.handle.net/10171/65975 | - |
dc.language.iso | en | - |
dc.rights | info:eu-repo/semantics/openAccess | - |
dc.title | Phase 1b Study of Isatuximab in combination with bortezomib, cyclophosphamide, and dexamethasone in newly diagnosed, transplant-ineligible multiple myeloma patients | - |
dc.type | info:eu-repo/semantics/other | - |
dc.description.note | This is an open access article distributed under the terms of the Creative Commons AttributionNonCommercial-ShareAlike 4.0 License, | - |
dc.identifier.doi | 10.1097/HS9.0000000000000829 | - |
dadun.citation.number | 2 | - |
dadun.citation.publicationName | HemaSphere | - |
dadun.citation.startingPage | e829 | - |
dadun.citation.volume | 7 | - |
dc.identifier.pmid | 36751513 | - |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.